Diabetic Shoes Market to Reach USD 16.0 Billion by 2033, Growing at a 6.4% CAGR

The global diabetic shoes market is experiencing strong growth and is projected to reach USD 16.0 billion by 2033, up from USD 8.6 billion in 2023. This expansion reflects a compound annual growth rate (CAGR) of 6.4% during the forecast period, driven by increasing awareness of diabetes-related foot complications and the rising prevalence of diabetes worldwide.

Diabetic shoes are designed to prevent and alleviate foot problems commonly associated with diabetes, such as neuropathy, poor circulation, and ulcers. With diabetes becoming more prevalent globally, particularly among aging populations, the demand for specialized footwear that offers comfort, support, and protection has risen significantly. Diabetic shoes are now widely recommended by healthcare professionals as part of the management of diabetes, contributing to market growth.

Technological innovations in diabetic shoe design, such as the integration of memory foam insoles, advanced cushioning materials, and custom orthotic support, are further driving the market. The growing availability of diabetic shoes through both online and offline retail channels is making these products more accessible to consumers globally.

Key Takeaways:

The global diabetic shoes market is expected to grow from USD 8.6 billion in 2023 to USD 16.0 billion by 2033, at a CAGR of 6.4%.
Rising prevalence of diabetes and increasing awareness of foot health are key factors driving market growth.
Technological advancements in shoe design and better access through retail channels are fueling adoption.
Diabetic shoes are becoming a critical component in diabetes management, leading to widespread consumer demand.
Various Factors Propelling the Demand for Diabetic Shoes are

To minimize the danger of the consequences of diabetic foot ulcers and limb amputation, individuals are moving their choice toward preventative care, as the burden of diabetes affects many people worldwide.

The World Health Organization reports that more than 50% of diabetics who are at risk for limb injuries also have peripheral neuropathies, which has the additional consequence of raising mortality rates globally.

Since more diabetic patients are becoming aware of the benefits of wearing diabetic footwear, the market for diabetic shoes is expanding significantly on a global scale. Customized and predesigned diabetic shoes with certain key features are growing in popularity among diabetic patients worldwide.

Competitive Landscape

The top competitors in the diabetic footwear industry have made it a priority to offer consumers specialized solutions as one of their primary methods to capture a sizeable portion of the market. The leading players have also benefited from strategies like product launches and acquisitions to increase their market position in the diabetic footwear industry.

Latest Developments:

Diabetic footwear was introduced in December 2021 by Casa Everz Gmbh, the proprietor of the German footwear company Von Wellx. Based on internationally patented reaction zones technology, these diabetes sneakers. Famous doctor Walter Mauch is credited for creating it.
Anodyne, LLC, a significant supplier of clinical footwear products frequently prescribed for diabetic patients, reported in May 2022 that HealthEdge Investment Partners, LLC, a private equity group with a focus on the healthcare industry, has completed an investment in the business.
Enovis, a multinational provider of medical technology, bought 360 Med Care Pty Ltd, an orthopaedic company with headquarters in Australia, in May 2022. Throughout the orthopaedic care process, the objective is to enhance patient outcomes.

Key Players in the Market Include

Asics, Drewshoe, Incorporated, Orthofeet Inc., DARCO International, Inc., Clearwell Mobility Company, Supad, Aetrex Worldwide, Inc., Gravity Defyer Corp., Kinetec Medical Products Ltd, Horng Shin Footwear Co., Watts Footwear, DJO, LLC (Dr. Comfort), Advance Diabetic Solution, Dr. Zen Products, Inc., and Sensoria Health

Key Segments Covered in the Diabetic Shoes Market Report

By Product Type:

Dress Shoes
Running Shoes
Strolling Shoes
Others

By Patient Type:

Outpatient
Inpatient
By End User:

Men
Women

By Width:

Narrow
Medium
Wide
Others

By Sales Channel:

Direct Sales
Footwear Specialty Stores
Medical & Healthcare Centers
Online Retailers
Mono-brand Stores
Other Sales Channel

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan (APEJ)
Japan
The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

This release was published on openPR.